Relief Therapeutics Holding AG
RLFTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $53,045 | $21,935 | $114,484 | $212,436 |
| - Cash | $15,080 | $14,556 | $19,237 | $44,761 |
| + Debt | $2,143 | $2,965 | $3,064 | $3,014 |
| Enterprise Value | $40,108 | $10,344 | $98,311 | $170,689 |
| Revenue | $8,417 | $6,033 | $6,081 | $3,321 |
| % Growth | 39.5% | -0.8% | 83.1% | – |
| Gross Profit | $5,842 | $4,297 | $4,831 | $2,571 |
| % Margin | 69.4% | 71.2% | 79.4% | 77.4% |
| EBITDA | -$16,580 | -$108,036 | -$49,022 | -$32,692 |
| % Margin | -197% | -1,790.8% | -806.2% | -984.4% |
| Net Income | -$17,119 | -$98,181 | -$50,790 | -$34,705 |
| % Margin | -203.4% | -1,627.4% | -835.2% | -1,045% |
| EPS Diluted | -1.37 | -8.35 | -4.8 | -3.86 |
| % Growth | 83.6% | -74% | -24.4% | – |
| Operating Cash Flow | -$2,916 | -$17,612 | -$24,126 | -$35,718 |
| Capital Expenditures | -$172 | -$446 | -$521 | -$13,708 |
| Free Cash Flow | -$3,088 | -$18,058 | -$24,647 | -$49,426 |